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The knee is a complex joint consisting of three anatomically and kinematically 
different compartments; the medial, the lateral and the patellofemoral compartment. 
When developing painful and disabling osteoarthritis (OA), there are different 
treatment options. Conservative treatment consisting of pain medication, injection 
therapy, physiotherapy and exercises can delay or prevent surgical treatment in many 
patients. However, many OA patients will need knee replacement surgery if all other 
fails. Most of these patients need a total knee arthroplasty (TKA), but in many cases 
with isolated unicondylar OA, unicompartmental knee replacement (UKA) is 
sufficient. 
Knee replacement surgery is rapidly increasing in Norway and worldwide. Both total 
knee and unicompartmental knee arthroplasty surgery are technically difficult 
procedures with multiple possible pitfalls perioperatively. The procedures require 
thorough knowledge of the bony and soft tissue anatomy and kinematics, as well as 
proper surgical technique and experience with the implants and concomitant 
instruments. 
The purpose of Paper I was to investigate whether there was a correlation between 
annual hospital procedure volume and the risk of revision in total knee arthroplasty 
using data from the Norwegian Arthroplasty Register. We found a significantly 
higher revision risk following total knee arthroplasty in low-volume hospitals in 
comparison to high-volume hospitals. 
In Paper II we compared high and low-volume hospitals regarding risk of revision in 
patients operated with the Oxford III UKA based on data from the NAR. We also 





higher hospital volumes were beneficial for improved survival of the Oxford III 
implant. 
Paper III was an expansion and further development of Paper II, investigating the 
effect of hospital procedure caseload on the risk of revision upon the usage of Oxford 
III UKA in the four Nordic countries using data from the Nordic Arthroplasty 
Register Association database. In this study we used a combination of three different 
methods of calculating annual hospital procedure volume. Lower volume hospitals 
had inferior results in all 3 methods of analysis as well as in the combined model with 
a 3-year moving average estimate. 
In conclusion, to optimize knee arthroplasty results and to avoid high rates of 
revision, acceptable procedure volumes should be achieved. TKA patients operated in 
hospitals performing more than 100 cases per year had a lower risk of revision. UKA 
patients operated in hospitals performing >40 cases per year had the lowest risk of 
revision in the NAR, whereas UKA patients in the NARA had a higher risk of 




1.1 The Osteoarthritic Knee 
1.1.1 Epidemiology and Kinematics 
Age is the strongest risk factor for 
osteoarthritis (OA) indicating a reduction in 
regenerative capacity and accumulation of 
risk factors and it is more common in 
women than in men (1). Injury can cause 
damage to the menisci, ligaments and 
cartilage, and increases the risk of 
development of OA more than 4 times (2). 
Obesity is a known risk factor increasing 
the load on the knee joint and the risk of 
OA by more than 3 times (3) and obesity is 
increasing the future need for knee 
replacement by 6.2 for men and 11.1 
for women in a study from Apold et 
al (4) (Fig.1). 
Cartilage is regulated by chondrocytes which upon activation can produce multiple 
inflammatory response proteins with both pathogenetic effects and with potential remodeling 
effects (1). 
Tibial and femoral bone morphology as well as limb malalignment with a varus and valgus 
knee can predict development of knee osteoarthritis. Furthermore, with leg length inequality 
of 1 cm or greater the risk of knee osteoarthritis is almost two times higher in the shorter 
than in the longer limb. 
Fig.1 Healthy knee(top), OA knee (left bottom) and 
knee replacement (right bottom). By permission of 
Mayo Foundation for medical Education and 
Research. All rights reserved. 
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Kinematics during gait is altered in severe OA of the knee, 
due to changes in the biomechanical properties of 
the cartilage and menisci (5) (Fig.2). In a normal 
knee, on average 58% of load, is transmitted through 
the meniscus and 42% through the uncovered cartilage (6). Rotational geometry can be 
altered due to coronal alignment differences in the osteoarthritic knee. Limb alignment is an 
important factor in developing OA and increasing the progression of OA in the overloaded 
compartment of the knee joint (7, 8).  
Valgus knees have the highest degree of internal rotation (9). Osteoarthritis in a valgus knee 
is commonly located in the lateral compartment due to increased load laterally. Previous 
lateral meniscectomy or a tibial plateau fracture could be predisposing factors for lateral OA. 
Lateral osteoarthritis also commonly has a posterior location (10), thus is most commonly 
visible in radiographs in flexion.   
Tibial torsion can be significantly reduced in OA patients with varus malalignment (11), 
probably due to the tight popliteus tendon in the severe varus OA knee. Medial osteoarthritis 
is the most common feature (Fig.3), and an anteromedial location is most common assuming 
the ACL is functional. White et al described medial tibial plateau excised from a series of 
Oxford UKA, all with intact ACL and all with central and anterior cartilage erosions (12). 
Isolated medial OA is a common disease of the knee.  
Fig.2 Damaged cartilage (OA) in 
all 3 compartments. By courtesy 
of Oxford University Hospitals 
NHS Foundation Trust. 
Fig.3 Medial OA in a varus malaligned knee. By permission 
of Mayo Foundation for medical Education and Research. 
All rights reserved. 
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Sometimes the patellofemoral joint is affected by cartilage degeneration, probably due to 
normal wear and tear and is asymptomatic. In a few cases, patellofemoral joint OA can lead 
to a painful knee with bone-on-bone and lateralization of the patella commonly caused by 
trochlear dysplasia. The need for a patellar joint replacement is still debated both for TKA 
(13-17) and for UKA (18-21). 
In the NAR, OA contributes to 90% of reported diagnoses leading to total knee replacement 
and OA is the cause in 95% for unicompartmental knee replacement. 
1.1.2 Diagnosing Knee Osteoarthritis 
Pain and loss of mobility due to osteoarthritis of the knee is the most common reason for the 
initial patient-surgeon contact to discuss knee replacement surgery. If lifestyle modifications 
such as weight loss in obesity have been tried as well as strengthening exercises, surgical 
alternatives such as unloading of the affected compartment or repair of localized cartilage 
lesions should be considered before knee replacement surgery (30). 
Arthritis of the knee can be either monoarticular or part of an oligo- or polyarticular disease. 
In addition to osteoarthritis, inflammatory diseases such as rheumatoid arthritis and 
spondylo-arthropathy often require arthroplasty surgery (22). 
Sometimes the osteoarthritis is secondary to previous trauma or injury to the bone, cartilage, 
meniscus and/or ligaments of the knee. Many of these patients have had previous surgery to 
the knee. Pain is the most predominant symptom of OA in addition to swelling and loss of 
mobility. The pain is often relieved by rest. Night pain and morning stiffness is uncommon. 
Pain on active or passive movement, local tenderness, crepitus, joint swelling and quadriceps 
muscle atrophy are typical features on clinical examination. 
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Single compartment involvement of the joint is most common in the medial compartment, 
but can also be presented as retropatellar OA or isolated lateral OA (23). Radiographic 
imaging confirms the diagnosis of OA. 
Since the knee has three compartments, anteroposterior, 
mediolateral and patella skyline views are recommended 
(Fig.4 and Fig.5). Joint space narrowing, subchondral 
sclerosis and osteophytes are common findings. MRI can 
detect early changes in OA but is not necessary to 
establish the indication for joint replacement surgery. 
Diagnostic arthroscopy to determine whether there exists 
an indication for surgery is rarely indicated. Planning 
before knee replacement surgery also involves 
determination of the limb axis to measure the Hip-Knee-
Ankle angle (Fig.6).  
Fig.4 AP (anteroposterior) and ML (mediolateral) view of 
tricompartmental OA of the left knee. 
Fig.6 Long axis anteroposterior view 
radiograph of patient with severe valgus 
malalignment and lateral OA. She also 
has severe dysplasia of her left hip. 
Fig.5 Patella skyview 
radiograph  with bone-on-bone 
lateral patellofemoral OA. 
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Varus/valgus stress x-rays or Rosenberg views (45 degrees of flexion in standing AP view) 
(24) can be useful when planning for unicompartmental knee arthroplasty (Fig.7).
Assessment of the ligament status is done clinically and is important considering the choice 
of arthroplasty. A ML view gives valuable information of the status of the cruciate 
ligaments. 
Fig.7 Rosenberg view with 45˚ 
flexion in AP view, visualizing 
posterolateral OA. 
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1.2 Total Knee Arthroplasty 
1.2.1 Introduction and Indication for Surgery 
Multiple factors may affect the outcome of total knee arthroplasty (Fig.8) and the patient 
satisfaction has been reported to vary between 80-90% (25-27). Patient satisfaction and 
outcome after knee arthroplasty varies between studies, and is multifactorial (28). 33-54% of 
patients reported residual symptoms and functional problems in a recent national multi-
center study (29).  
The knowledge and understanding of the knee replacement surgery has evolved during the 
last decades, leading to better and more durable implants. TKA has proved better results than 
non-surgical treatments (30). However, Skou et al. also showed that 74% of the patients 
receiving non-surgical treatment did not undergo TKA before the 12-month follow-up. 
Additionally, TKA was associated with a high number of serious adverse events. Knee 
replacement surgery could be recommended when various conservative treatment options no 
Fig.8 Total knee arthroplasty viewed from the frontal plane 
(left) and the side view (right). By permission of Mayo 
Foundation for Medical Education and Research. All rights 
reserved. 
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longer provide adequate pain relief or functional improvement. Conservative treatment 
options in knee OA are pain medication and injection therapy (31, 32) in addition to 
physiotherapy with strengthening and mobility exercises (33). Other surgical treatment 
options could also be considered in earlier stage OA such as various cartilage surgery 
techniques (34), or limb correcting osteotomy (35). 
Degree of pain and functional impairment combined with sufficient radiographic cartilage 
loss are factors in decision-making regarding indication for surgery. 
Implant related issues that are debated, are resurfacing of the patella (13), cemented or 
uncemented fixation (36), and fixed versus mobile bearing (37).   
1.2.2 Implant Designs 
There are fixed bearing and mobile bearing designs in knee arthroplasty. Mobile bearing 
knee arthroplasty has a mobile polyethylene insert where the purpose is better 
kinematics and improved range of motion. The intention is reducing wear of the 
polyethylene by reducing point loading, but these goals have not been achieved 
compared to the fixed bearing designs. There are pros and cons to both designs and the 
surgical principles are mainly the same for fixed and mobile bearing components. 
Currently there are no major differences in the risk of revision comparing the two 
designs (38). An international meta-analysis based on registry data found a greater risk 
of revision in mobile-bearing non-posterior-stabilized designs (37). In the NAR, 28.7% 
of knee replacements are mobile bearing designs.   
There are different levels of constraint in knee arthroplasty. The most constraint is a 
hinged prosthesis. The indication for a hinged design is medial or lateral collateral 
ligament deficiency/insufficiency or significant axial malalignment with a varus or valgus 
axis of more than 20 degrees where the polyethylene height may exceed 20mm (39). It is 
however recommended to use as little implant constraint as possible. In the majority of 
cases, no constraint is necessary as in posterior cruciate retaining implants (CR). It is 
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dependent on functionally intact soft-tissues around the knee and an intact posterior cruciate 
ligament in particular. Only the anterior cruciate ligament is sacrificed. In posterior cruciate 
deficient knees a posterior cruciate substituting design (PS) is necessary. For primary knee 
arthroplasty, CR and PS are most commonly used, but the preference differs between 
countries, hospitals and surgeons and remains a matter of discussion.  Most studies on 
the subject addresses clinical and functional differences, but no clinical relevance has  
been found (40, 41). An international registry based study showed higher revision rates 
with PS knees (42). Intercondylar stabilizing implants (CCK) has a taller and broader 
central cam post compared to the PS cam that can provide varus-valgus stability and 
rotational stability as well (43). This design in addition to the hinge design is rarely used 
in primary cases, and there are limitations to the existing literature regarding long-term 
results and indications for usage (44). In the NAR, only 3% of primary knee 
replacements are PS, CCK and hinged implants. 97% are CR designs including the 
mobile bearing implants. 
1.2.3 Fixation Method 
Cemented knee arthroplasty has been the golden standard of fixation supported by long-
term survival rates in registries worldwide. Cementing technique with optimal 
penetration into the cancellous bone is dependent on the bone preparation and the 
management of the cement (45). The bone cuts should be precise allowing 1 mm of 
cement mantle to a tight fit. Ideal cement penetration should be 3-5 mm (45). In hard 
sclerotic bone it is recommended to drill several small holes in the bone to facilitate 
cement into the bone.  It is important to remove all excess cement to avoid third-body 
wear and damage to the polyethylene component. The polymerization process from 
liquid to solid state takes several minutes, varying with temperature and humidity and 
also from one cement brand to another. 
Earlier failures of cementless fixation in TKA have been loosening of the tibial plateau 
or early polyethylene wear of the metal-backed patellar components. Improved fixation 
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and bony ingrowth depends on the structure and quality of the component surface. 
Better materials in addition to bone growth-enhancing factors could improve the 
cementless knee replacement in the future (36). Some surgeons use a hybrid technique 
of cemented tibia component and a cementless femoral implant (46, 47). In the NAR, 
83.6% are cemented, 4.9% are uncemented and 11.5% are hybrid with cemented tibial 
and uncemented femoral components (62). 
1.2.4 Patella Resurfacing 
The patellofemoral joint is complex, and individual variations are common regarding 
alignment and patellar tracking (48). The kinematics of the patella is changed in TKA and is 
dependent of the design of the femur. Femoral components used in earlier implant designs 
had a shallow trochlear groove and were so-called patella-unfriendly (Fig.9). Patellar 
components were more commonly used to avoid anterior knee pain. Current knee 
arthroplasty designs have a deeper trochlear groove with an elevated lateral flange that are 
more patella-friendly and facilitates a more normal tracking throughout the flexion 
movement (Fig.10). In addition, patellar maltracking is not so common in newer designs due 
to the possibility to externally rotate the femoral component leading to lateralization of the 
trochlear groove. Internal malrotation of the tibia component could also affect the patellar 
tracking negatively (49, 50).  
Fig.9 Private photo after revision of knee 
arthroplasty implanted in 1989 in Haugesund 
Rheumatism Hospital in a rheumatoid patient. 
The femoral component has a non-excisting 
trochlear groove and therefore so-called patella-
unfriendly design. The implant was known as 
Accord, the Johnson/Elloy concept by Thackray. 
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There are two different patellar designs in use, the inset or the resurfacing design (51, 52). 
The common method of insertion is medial placement and resection of the unresurfaced 
lateral facet, thus improving patellar tracking. 
In Norway the majority (98%) of knee arthroplasty is without a patellar component (16), but 
there are different traditions in other countries where inserting a patellar component in total 
knee arthroplasty is preferred and recommended (53). Some surgeons prefer to resurface the 
patella in cases of severe patellofemoral osteoarthritis only and otherwise do not use it (13, 
15, 54).  
1.2.5 Failure Mechanisms 
Aseptic loosening, instability, malalignment, and periprosthetic infection are the primary 
failure mechanisms leading to revision surgery after TKA, whereas there have been a 
reduction in implant-associated revisions such as those due to polyethylene wear. Common 
early and intermediate failure mechanisms, such as deep prosthetic infection, instability, and 
malalignment (55) remains common. Furnes et al. found that unicompartmental knee 
replacement was associated with an increased risk of revision due to pain alone, aseptic 
loosening of the tibial and of the femoral component and periprosthetic fracture as compared 
Fig.10 Private photo of extracted femroral component 
after revision surgery,  demonstrating a deep trochlear 
groove with elevated lateral flange, so-called patellar-
friendly design. 
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with total knee replacement. Unicompartmental knee replacement was associated with a 
lower risk of infection compared with total knee replacement (56). Also, Leta et al. found 
that deep infection was the most frequent cause of failure of revision of aseptic total knee 
arthroplasties (57). In Norway, 19 % of revisions of non-resurfaced total knee arthroplasties 
done for knee pain between 1994 and 2011 were secondary patella resurfacing. However, 
more than a third of the patients were dissatisfied with the result after the procedure (58). 
1.3 Unicompartmental Knee Arthroplasty 
1.3.1 Indications and Contraindications 
Pain on standing or walking is the principal sign of anteromedial OA of the knee. In this 
context we only focus on the medial UKA, since the definition of a UKA also could mean an 
isolated lateral or a patellofemoral arthroplasty. The localization of the pain is commonly on 
the medial side of the joint, but not always. The severity of the pain decides the need for 
surgery. 
Full-thickness cartilage loss with bone-on-bone on the medial side on the x-ray is a 
requirement for surgery. In addition, the cartilage on the 
lateral side should be intact. A plain standing AP view, a 
Rosenberg view or stressed films are the different options to 
demonstrate this (Fig.11). The varus deformity should be 
correctable in 20 degrees of flexion (59). 
Intraoperatively the ACL should be intact and functional and 
the lateral side should be inspected for possible central 
articular cartilage ulcers (60, 61). 
Inflammatory arthritis is a contraindication as well as 
previous high tibial osteotomy. Absent or damaged 
 Fig.11 Varus stress radiograph 
demonstrating full cartilage loss in 
the medial compartment of the knee. 
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ACL, PCL and/or MCL are also contraindications (59). Lateral cartilage loss is a 
contraindication. High BMI, high activity level, age <60, chondrocalcinosis and 
patellofemoral OA were 5 contraindications proposed by Kozinn and Scott(21), but later 
opposed by users of the Oxford mobile-bearing implant (60, 61). 
1.3.2 Surgical Technique 
Unicompartmental knee replacement comprises 10.5% of all knee arthroplasty in the NAR 
from 1994-2014. 72% of all UKA in Norway since 1994 was Oxford III mobile bearing 
implants. There are both mobile and fixed bearing implant designs in UKA. 8 different fixed 
bearing implant brands have been utilized in small numbers from 1994 till now (62).  
The main object is to restore the affected medial compartment and also restoring the 
ligament tension both in flexion and extension (Fig.12). The ligaments are never released in 
UKA; they are restored to normal tension by the right size menisceal bearing. The ligament 
tension should be equal throughout the entire range of motion. The presumed advantage is 
preservation of undamaged structures such as the lateral compartment and the anterior 
cruciate ligament.  
Fig.12 Isolated medial osteoarthritis of the left knee with intact ligaments and 
implanted Oxford unicompartmental knee replacement. By permission of 
ZimmerBiomet. All rights reserved. 
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1.3.3 The Oxford Uni Knee 
The Oxford UKA has an unconstrained mobile bearing. It articulates with the femoral 
condyle with the upper concave surface and the flat surface against tibial surface (59) 
(Fig.13). The Oxford phase 1 was first introduced in 1974 and Oxford phase 2 in 1987. They 
were both implanted through a large open approach as in TKA. In 1998, the Oxford phase 3 
was introduced, and the short minimally invasive incisions were introduced. 5 different sizes 
for the femoral component replaced the single size in phase 1 and 2. The tibial plateau 
became side-specific. Instruments were miniaturized to allow minimally invasive technique. 
The concept of using spherical and flat articular surfaces on the two metal components and a 
fully conformed menisceal bearing was to minimize polyethylene wear and to restore natural 
mobility and stability by retaining all ligaments (50).  
Fig.13 The Oxford mobile bearing implant design with a mobile menisceal 
bearing where the meniscofemoral interface is a “ball-in-socket” due to the 
spherical femoral component and the meniscotibial interface is a “flat-on-






1.3.4 Failure Mechanisms 
Long-term failure rates of uni knees have been high in several registries compared to total 
knee arthroplasty (56, 63). Loosening of the components or luxation/spin out of the insert is 
usually due to technical issues. Anatomic bearings were designed to prevent 90° of bearing 
rotation on the tibial tray. Radiolucency has been reported in cemented Oxford UKA 
components and could be interpreted as a sign of loosening, but should be radiographically 
interpreted with caution (64, 65). Fracture due to collapse of the tibial plateau is another 
known failure mechanism in knee replacement surgery, but new instrumentation has also 
been developed to avoid that complication. Development of lateral OA occurs in some 
patients and presents as pain and radiographic lateral OA (Fig.14). Revision due to pain 
alone is thought to be a problem of inappropriate surgical indication (59), both for the 
primary and the revision procedure. Persisting pain after primary surgery where the degree 
of OA was modest could suggest that the indication for surgery was doubtful. This issue has 
been explored comparing revisions for pain alone in UKA and TKA with conflicting results. 
The argument whether the threshold for revising a UKA is lower than for the same level of 
patient reported pain after a TKA is controversial (66, 67). Revising a TKA is considered 
more difficult than revising a UKA since one occasionally could get by just replacing the 
UKA with a TKA. However, that is not always the case, and stems and augments are 
frequently required for revision from a UKA to a TKA (62, 68) depending on the depth of 




Fig.14 Progression of lateral OA is also a well-
known cause of revision in UKA surgery. 
Private photo from revision surgery of a medial 
Oxford III UKA due to painful progression of 
lateral OA 7 years after primary surgery. 





1.4 Impact of Procedure Volume in Surgery 
1.4.1 Procedure Volume 
Superior results after knee replacement surgery depends on a variety of factors. The main 
aim of our studies was to show the association between procedure volume and risk of 
revision after both total and unicompartmental knee arthroplasty. The number of TKA 
procedures has increased gradually over the years whereas UKA did not have the same 
increase over time  (62) (Fig.15). Using the year 2008 as an example, the mean annual 
hospital volume for TKA was 60 compared to 8 for UKA. 
 
Fig.15 Bar graph from the NAR report 2016 showing the distribution of TKA with and 
without patellar components and UKA. 
  
To become a specialist in orthopaedic surgery it is mandatory to perform 15 TKA, whereas 
UKA is not a mandatory procedure. 
 
 
TKA with patella 
TKA without patella 
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There still is an ongoing debate in a variety of surgical specialties as well as in orthopaedic 
surgery whether procedure volume influences patient outcome and reoperation rates. The 
expectation that experienced surgeons or units performing high volume surgery impacts the 
outcome has been debated by numerous authors. Chowdhury et al. (69) reviewed 163 
publications within 13 surgical specialties and showed 74% significantly better outcome for 
high volume units and surgeons. Major oncological surgical procedures such as 
oesophagectomy and pancreatectomy has established major differences in mortality (70) and 
the same results have been shown for breast cancer and lung cancer (71, 72) regarding 
impact of high volume surgery. 
Whether or not there should be established a threshold value for procedure volume in 
surgery below which surgery should be avoided is debated. Pediatric cardiac surgery has 
established a minimum threshold volume in different studies varying from 100-300 
operations annually. There are also literature that shows no association between procedure 
volume and outcome regarding the previously mentioned conditions (73).  
There are papers reporting higher mortality rates after joint replacement surgery in low 
volume units, even though this is a rare complication (74, 75). Shorter hospital stays in total 
joint arthroplasty has been demonstrated for high volume units in both Denmark and Finland 
(76, 77). Judge et al. found an increased risk of death and pulmonary embolus after total hip 
and knee arthroplasty in low volume hospitals (78). Others have found that patient related 
factors were more important predictors of outcome than volume (79). Threshold values have 
also been proposed by several studies regarding TKA, varying between 15 and 100 a year 
(80-82). 
Some papers present only hospital volume, others surgeon volume and some both. The 
relationship between the two was studied by Shrag et al. (83).  They demonstrated that high 
volume surgeons in high volume hospitals had the best results regarding colorectal resection. 
Low volume surgeons had better results if they worked in a high volume hospital than in a 
low volume hospital. Medium volume surgeons achieved excellent results in medium or high 
volume units. That study indicated that volume of a hospital has equal or greater effect on 





Hospital volume is one of many predictors of and possible consequences of hospital quality. 
In a study by Curry et al. (84) hospitals in the high-performing and low-performing groups 
differed substantially in the domains of organizational values and goals, senior management 
involvement, broad staff presence and expertise in acute myocardial infarction (AMI) care, 
communication and coordination among groups, and problem solving and learning.  
 
1.4.2 Hospital Volume 
Patient survival after open heart surgery and the findings of a relationship with institutional 
volume led to one of the first recommendations for minimum hospital volume (85, 86). 
Hospitals in which 200 or more of these operations were done annually had death rates, 
adjusted for case mix, 25 to 41 per cent lower than hospitals with lower volumes.   
Colorectal cancer surgery has also been investigated extensively focusing on provider 
volume and the effect of specialization (87). For rectal cancer, there was a significant 
association between high-volume hospitals and improved 5-year survival (HR=0.85, 95% CI 
0.77 to 0.93), but not with operative mortality.  Further recommendations of regionalization 
appeared in procedures like hip replacement (85, 88) as well as multi injury trauma care to 
reduce adverse outcomes (89). Since then, numerous publications have documented the 
correlation between caseload of procedures and the postoperative outcome for various 
surgery (81, 90, 91). A recent study using Medicare data, showed that despite recent 
improvements in surgical safety, high procedure volume hospitals still had significantly 
lower mortality rates than lower volume centers for all procedures examined (92).  
Multiple studies have been published regarding TKA and the effect of procedure volume 
using with various outcome measures, such as complications and mortality (80, 81, 93), 
length of hospital stay (94, 95) and functional outcome (96). Starting this study, only a few 
studies existed on the relation between procedure volume and the risk of revision regarding 





On UKA there was one existing study on the subject of hospital volume in correlation to 
revision risk for UKA; a Swedish register study by Robertsson et al (97) finding a decreased 
risk of revision in hospitals with a caseload of more than 23 procedures a year. They also 
concluded that technically demanding implants were most sensitive to the routine of surgical 
management, in this case the Oxford menisceal knee (Biomet Ltd, Bridgend, UK). 
 
1.4.3 Surgeon Volume 
In a systematic review and metaanalysis, surgical outcomes for surgeons performing a 
procedure once a month or less had increased rates of adverse outcomes in gynecology, 
gynecological oncology and urogynecology (98). Kreder et al (1997) found that there were 
higher mortality rates, more infections, more revisions and other complications after total hip 
replacements if the patient had been managed by low-volume surgeons (88). Others have 
also found this correlation in other types of surgery (99), and in TKA there is some 
documentation of the surgeon volume effect (96, 100).  
The first registry study finding a lower risk of revision by high volume surgeons performing 
Oxford III UKA was from The New Zealand National Joint Registry  (101). Surgeons 
performing more than 10 Oxford III UKA annually had fewer revisions than the lower 
volume surgeons.  
Baker et al (102) has later demonstrated a minimum of 13 procedures per year to gain 
comparable results with high-volume operators. Additionally, they found a greater revision 
risk for low-volume surgeons at low-volume centers compared too high-volume surgeons at 
high-volume centers. Bini et al. (103) found similar results in the US population with higher 
revision rates for patients operated by surgeons performing less than a mean of 12 UKA a 
year. 
 A recent study from the National Joint Registry (NJR) of England and Wales found a 
correlation between surgeon caseload and implant survival of both UKA and TKA (104). 





Studies related to outcome after UKA has focused on surgeon and hospital procedure 
volume over the years due to the presumption that surgical skill is a predicting factor for 
success. National registry studies have been recommended for assessment of the outcome of 
implants to avoid potential bias, and the existing studies confirm the importance of surgical 
caseload (61, 97, 101, 102, 105).  
 
1.4.4 Learning Curve 
Supervision by more experienced surgeons to ensure appropriate skills performing specific 
procedures is essential when learning new techniques (Fig.16). Achieving sufficient 
experience to minimize complications and inferior results takes a certain amount of time and 
should not be rushed. Learning curve is an ongoing process, to be considered even for 
experienced surgeons with a large time-interval between operations(106). Increasing volume 
and year of practice has been associated with improved performance, but may deteriorate 









 Fig.16 Private photo in the operating room at Kysthospitalet in Hagavik 





Complex skills must be achieved in surgical training and the level of capability to acquire 
the desired level of competency will be individual. Price et al. demonstrated a significant 
correlation between experience and performance during diagnostic knee arthroscopy in a 
simulator study comparing trainees of different levels to consultants. Consultant 
performance was only reached by fellows with experience level of >150 arthroscopies. They 
found significant improvement in performance with increasing experience (108). 
The assessment of technical proficiency is of paramount importance in the training in many 
surgical procedures. Young et al. found that the average intern required approximately 19 
intubation attempts to complete the learning curve experience whereas there was no learning 
curve for airway assessment (109). For UKA there is a learning curve to improve surgical 
technique (110, 111). A study has also demonstrated the importance of continuing medical 
education courses from manufacturers and experts in the field (112).  
However, surgical expertice exceeds  technical and operative competency, especially in 
arthroplasty surgery. Surgical indication for both primary surgery and decision-making prior 
to revision surgery is  crucial determinants for the outcomes and critical for revision rates in 
knee replacement surgery. Criteria for levels of performance before practicing independently 
in addition to careful education in decision making will improve results in all surgical 
specialities. 
 
1.4.5  Calculation of Procedure Volume 
 
Many different definitions have been used for hospital volume, and between 2 and 5 volume 
categories have been used. How to calculate annual procedure volume or caseload has also 
varied between studies. Previous studies on procedure volume have used an average volume 
over the whole study period. More recent studies have counted each year separately or used 
percentage/usage of UKA of the total volume of knee replacements. This limits the 





One method of determining hospital volume used in several papers is an average annual 
volume defined as the mean procedure volume of the hospital in a given period of time. 
Average volume over the whole time period does not take the variability into account, and 
could be a valuable and easy method where the caseload is relatively constant from year to 
year.  
Another method of measuring annual hospital volume is counting procedures or patients 
operated upon in each hospital each year separately. The results for the different volume 
groups are compared accordingly. In this method, hospitals could contribute to different 
volume groups depending on the actual number of procedures or patients operated that 
particular year.  
Usage/proportion of rare procedures compared to the total proportion of similar procedures 
occurring in larger numbers per hospital is a third method of evaluating surgical caseload. 
The usage or percentage takes into account the total procedure volume of surgery, not only 
the specific procedure of interest. The method assesses the differences in indication 
threshold for UKA compared to all knee arthroplasty in percentage. 
 




















‘Funnel plots’ can be used as a tool for institutional comparison, assessing comparison 
between outcome and volume of cases. 3 standard deviations are commonly used as a 
demarcation if any hospital lies outside the 99% limits. Using funnel plots as an initial 
assessment of the relationship with volume, hospitals with diverging performance will stand 
out as a point outside the funnels (Fig.22).  
As hospital volume could be a proxy for surgeon experience, a moving average with each 
average based on for example the last 3 years would smooth out year-by-year fluctuations in 
annual procedure volume. This could prevent bias regarding surgeons leaving the hospital 
leading to a sudden decrease in volume and also a drop in experience. 
Common for existing UKA procedure volume studies is the generally low procedure 
numbers per surgeon and hospital. In the New Zealand Joint Registry, the average hospital 
volume of unicompartmental knee replacements in 2014 was 21, and the average number of 
UKA per surgeon was 10. 39 of the 40 registered surgeons performed less than 5 UKA a 
year (113).(ref register). In the Swedish register study, a hospital threshold value of 23 UKA 
a year was proposed as a minimum caseload and the study revealed that 75% of the hospitals 
performed less than 23 UKA a year. 25% of the hospitals performed less than 7.8 UKA a 
year (97). In a more recent study from England and Wales, 82.8% of the hospitals performed 
less than 100 UKA procedures during the 8 year study period and 85.6% of the surgeons 
performed ≤50 procedures during the same study period (102). Similarly, another England 
and Wales registry study found 5.4 UKA a year per surgeon on average and 25% had a mean 
caseload of only 1 UKA per year. In comparison, the mean annual TKA number per surgeon 
was 33.6. In the latter study, surgeon annual volume was divided into groups of <10, 10-30 
and >30. Another study from Liddle et al. investigated the optimal UKA usage defined as the 
percentage of knee arthroplasty practice comprised by UKA. They concluded with 
acceptable results with 20% usage and optimal results with usage between 40-60% (61). 
The different calculation methods have never been assessed against each other and the 
described statistical analyses can lead to conflicting results. How to best analyze institutional 
performance is a highly relevant topic with several methodological issues. This study is a 





2. AIMS OF THE STUDY   
The main objective of this thesis was to determine if there was a relation between hospital 
procedure volume and the risk of revision for all reasons and for specific causes in knee 
arthroplasty surgery based on data from the Norwegian Arthroplasty Register and the Nordic 
Arthroplasty Register Association. The second objective was to assess different statistical 
methods used in calculating procedure volume. 
The specific aims of the 3 papers were: 
Paper I    
 To establish the numbers of TKA procedures performed annually at all hospitals in 
Norway  
 To investigate a possible association between low hospital procedure volume and 
high risk of revision regarding TKA for 5 different volume groups using hospital 
volume data from the NAR. 
 
Paper II   
 To establish the numbers of UKA procedures performed annually at all hospitals in 
Norway.  
 To investigate a possible association between low hospital procedure volume and 
high risk of revision regarding the Oxford III UKA, using 4 different volume groups 
using hospital volume data from the NAR.  
 To investigate possible variations in the reasons for revision between the volume 
groups.     
                
Paper III  
 To determine the current practice in the Nordic countries regarding the annual 





 To investigate a possible association between low hospital procedure volume and 
high risk of revision regarding the Oxford III UKA, using hospital volume data from 
the NARA. 
 To assess different statistical methods used in calculating procedure volume. 











3.1   The Norwegian Arthroplasty Register 
The Norwegian Orthopaedic Association (NOA, (NOF in Norwegian)) initiated the 
establishment of the NAR in 1987 due to the lack of documentation regarding longevity of 
implants and the implementation of low quality hip replacement implants in the early 1980s. 
Only the Charnley hip implant had satisfactory long term follow-up results at 10 years. The 
remaining 49 implant brands utilized had no long term documentation available from clinical 
studies. From being a hip register, NAR developed into a joint register from 1994, including 
all other joint replacements.  
The main reason for establishing a nation-wide register was the introduction of un-
documented implants with high failure rates in the 1970s and 80s. Initially, it worked to 
reveal inferior implants and methods that increase the risk for revision as only patients with 
severe osteoarthritis were offered surgery. The intention later, when knee arthroplasty 
surgery became more popular, was also to improve the results and quality of treatment over 
time. 
Orthopaedic surgeons report to the NAR immediately after surgery by filling out a 1-page 
form (appendix 1) providing information regarding the patient, the surgical procedure and 
the choice of implants. Stickers with catalogue numbers to identify the implants are used. 
Revision surgery demands a new report using an identical form as the primary with added 
information about the reason and type of revision. The revision procedure is linked to the 
primary procedure by the patient’s unique personal identification number given to all 
inhabitants of Norway at birth or on immigration. 
Annual reports are published with information concerning the choice of implants, methods 





including comparison to other hospitals results. Peer-reviewed publications are presented in 
scientific journals (62). Implant specific results are only given in peer-reviewed publications 
to discuss the strength and limitations of the study (114-116). 
The NAR provides information on hospital procedure volume, but lacks information on 
surgeon volume and PROM data. Some cross-sectional studies have used PROM data 
obtained by postal questionnaire (16, 117, 118). The completeness of primary procedures 
was 96% and 89% for revision surgery between 2008-2014 (62). 
Currently, the NAR provides information regarding 68 271 primary knee arthroplasties from 
1994-2015. There are 229 published research articles associated with the NAR. 
There is an ongoing collaboration with the Nordic Arthroplasty Register Association 
(NARA) (119-121) as well as the International Consortium of Orthopaedic Registries 
(ICOR) (37) and the International Society of Arthroplasty Registers (ISAR) (122). 
 
3.2   The Nordic Arthroplasty Register Association 
The collaboration of the Scandinavian countries’ arthroplasty registers was established in 
2007 by creating a common database including hip replacements from 2008 and knee 
replacements from 2009. Denmark, Sweden and Norway were included initially, and Finland 
joined in 2010. This was enabled since the respective countries have similar health 
organizations, personal identity numbers and national joint registers. 
All 4 countries have different registration forms, different variables and some different 
definitions of variables. Therefore a common code set was defined that all the registers could 
provide. Every year a new dataset is made after discussion and consensus regarding 
inclusion or exclusion of variables. Selection and transformation of the respective data sets 
and de-identification of the patients, including deletion of the national civil registration 





Anonymous data are then merged into the common database using a safe data transfer site 
(123).  
The first studies focused on differences in patient demographics, surgical methods and 
implant brands (120, 121, 124). The main purpose was the ability to analyze a larger 
statistical material, which is an advantage especially for uncommon methods and implants. It 
reflects the current practice in 4 different countries (125). The NARA group has also 
published statistical guidelines for recommended analysis of arthroplasty registry data to 
improve the reliability and value of the research (126, 127).  
The knee dataset currently includes 390 525 primary knee arthroplasty operations performed 
during 1995-2012 (119). The NARA collaboration has resulted in numerous research 
projects and currently 19 publications. 
 
3.3   Hospital Survey – Surgeon Volume  
Since information on surgeon procedure volume is absent in the NAR, we performed a 
survey to gather this information otherwise. A hospital survey was constructed and sent to all 
hospitals known to perform knee replacements. We asked the chief consultant at the 
orthopaedic departments to fill out the received form and return it to the NAR. There were 
72% responders to the questionnaire after one reminder. We asked for the exact number of 
procedures per surgeon in the year of 2000 and 2009. These data were extrapolated -/+ 2 
years to increase the number of cases. A low volume surgeon was defined as a surgeon 
performing ≤10 TKA or ≤5 UKA a year, respectively. Hospitals were then categorized as 
low (if more than 66 % of the surgeons were low volume surgeons), medium (35-66% of the 
surgeons were low volume surgeons) and high (<35 % of the surgeons were low volume 





However, we did not include these results in the publications as the statistical validity was 
too low and we were not able to link the surgeons to the specific patients. Nevertheless, we 









4. METHODS AND STATISTICS 
 
4.1    Study Design 
Paper I and II were based on a population based register study with data collection from the 
NAR. The data collection was from 1994-2010 in paper I and from 1994-2012 in paper II.  
Paper III was a population-based register study with data collection from the NARA from 
2000-2012 with revision as endpoint. Revisions were linked to the primary surgery by the 
unique national identification number of the patient. Information on deaths or emigrations 
was retrieved from the Norwegian Resident Registration Office until December 2012 in 
paper I and II and similarly from the Nordic countries in paper III. 
 
4.2    Inclusion Criteria 
26 698 TKA registered in NAR were selected for inclusion in paper I, excluding UKA, TKA 
with patella components, uncemented components or cemented without antibiotics and more 
constrained than CR TKA. 92% of TKAs in Norway has been performed without a patellar 
component, and 96.7% are unconstrained implants. CR TKA without a patellar component 
cemented with antibiotics was the preferred implant choice for most hospitals in Norway. 
The NAR has registered UKA surgery since 1994 and Oxford III since 1999. The 2015 
report showed 11% UKA as primary knee arthroplasty surgery. 51 hospitals performed UKA 
surgery in 2012. 5 791 UKAs were registered in the study period from 1994-2012 in paper II 
and of these 4 460 cemented medial Oxford III UKAs were analysed from 1999. We selected 





Norway during the study period. Primary TKA, uncemented and cemented without 
antibiotics UKA and lateral UKA were excluded for analysis. 
The Oxford UKA was also the most commonly registered UKA implant in the NARA. 
Implant brand and type could be a source of confounding in comparison of revision rate 
according to hospital volume, and therefore all other brands and types than Oxford III UKA 
were excluded. Diagnoses other than OA were excluded as inflammatory disease is a 
contraindication. Additionally, uncemented knee arthroplasty, TKA, lateral UKA and 
hospitals with less than 10 Oxford III UKA implanted during the whole time period were 
excluded in paper III. We identified 4131 (31.6%) Oxford III implants in Denmark in 32 
different hospitals: 2180 (16.8%) in Sweden distributed among 18 hospitals, 3826 (29.6%) in 
Finland in 41 hospitals and 2849 (21.9%) in Norway in 35 hospitals. 
 
4.3    Hospital Volume Categorization 
In paper I, annual TKA hospital volume was categorized into 5 groups; 1-24, 25-49, 50-99, 
100-149 and 150+. In paper II we analysed 4 different annual UKA hospital volume groups 
with procedure volume from 1-10, 11-20, 21-40 and >40. Patients were entered into the 
hospital volume groups according to the number of procedures at their hospital in the year of 
surgery. Each year was examined individually for every hospital.  Consequently, many 
hospitals had inconsistent procedure volume over time and contributed to more than one 
volume group. The different hospital procedure volume groups were compared for the risk of 
revision. 
As paper III was an expansion of paper II comparing different methods of volume 





1. Volume calculation based on annual procedure hospital volume counting each year 
separately: We used quartiles to divide into 4 different annual hospital volume groups: 
<13, 13-25, 26-45 and >45.  
2. Average hospital procedure volume over a 13-year time span: Group 1 had an 
average annual hospital volume of less than 12, group 2 from 12-26 and group 3 had an 
annual average volume of more than 26 UKA per year. The measures were chosen based on 
equal sizing of the 3 groups. 
3. The usage/proportion of Oxford III UKA compared to the total proportion of primary 
knee replacement per hospital: we used a proportion of more or less than 20% UKA relative 
to all primary knee replacements as categorical variables with ≤20% used as reference. 
In the combined model in paper III, volume was used as a continuous variable, as categories 
are an average of the group and not a true cut-point estimate. I.e. the <13 group is actually 
the average within that group and not the estimate at 13. 
 
4.4    Patient and Procedure Variables 
Patient characteristics were assessed by descriptive analysis for the different hospital volume 
categories. In paper I and II, adjustments were made for sex, age and diagnosis. In paper I, 
age was used as a continuous variable, whereas in paper II age was categorized into 4 groups 
(< 60, 61–70, 71–80, and > 80). Diagnoses were divided into 2 groups (osteoarthritis (OA) 
and others). 
As many prosthesis brands had been used in small numbers in paper I and were associated 
with few revisions in each volume group, adjustment for brand was not feasible in the Cox 
analyses. Therefore, a subanalysis was performed including two commonly used implant 





these implants were some of the most commonly used and were well represented in all the 
volume groups.  
In paper III, confounding variables such as sex, age category (<55, 55-64, 65-74, ≥75), time 
period (2000-3, 2004-6, 2007-9, 2010-12) and nation were available and used for analysis in 
the NARA material. 
 
4.5    Statistics 
Survival analyses were performed with any revision of the implant as endpoint. Implant 
survival was defined as time from primary surgery to first revision. Revision was defined as 
complete or partial removal/exchange/addition of implant component(s). 
In paper I, II and III Kaplan-Meier survival percentages were reported and survival curves 
were constructed for the different hospital volume groups. The Cox regression model was 
used to evaluate the effect of volume on implant survival calculating hazard rate ratios (RR), 
both unadjusted and with adjustment for age, gender, diagnosis. They were presented with 
95% confidence interval (CI) and p-values relative to the lowest volume group.  All p-values 
less than 0.05 were considered to be statistically significant.  Adjusted Cox regression 
survival curves were constructed for hospital volume categories with volume as stratification 
factor. 
In paper III death as competing risk was investigated and frailty term for hospitals was added 
to the analyses of the 3 models. The combined Cox model included sex, age, calendar year 
of surgery, nation, Oxford III UKA annual hospital volume, proportion Oxford III UKA, and 
TKA annual hospital volume. A moving average was added to the combined model 
including a 3-year moving average estimate of annual hospital procedure volume of the 
Oxford III UKA. The revision risk was calculated for each hospital volume per year and then 






4.6    Revision Causes 
In paper II and III, reasons for revision were analysed in all the volume groups. In a material 
restricted to revised implants, the Pearson chi-square test was used to test whether 
proportions of specific revision causes differed among volume groups. The log-rank test was 
used to compare implant survival among volume groups with revision due to pain only, 
infection, loosening, dislocation, instability, malalignment, fracture, or to progression of 
osteoarthritis (OA) as endpoint (Paper II). Cox regression analysis was used to test whether 
proportions of specific causes of revision differed between the volume groups in the material 
including only revised implants. Relative risk with 95% CI was used to compare implant 
survival among the different volume groups with the different revision causes as endpoint 
for all 3 methods. The various reasons for revision were organized hierarchically with 






5. SUMMARY OF PAPERS I-III 
 
Paper I 
Influence of Hospital Volume on Revision Rate after Total Knee Arthroplasty with 
Cement 
Mona Badawy, Birgitte Espehaug, Kari Indrekvam, Lars B. Engesæter, Leif I. Havelin and 
Ove Furnes. 
J Bone Joint Surg Am. 2013 Sep 18; 95 (18): e131 
Background: The number of total knee replacements has substantially increased worldwide 
over the past ten years. Several studies have indicated a correlation between high hospital 
procedure volume and decreased morbidity and mortality following total knee arthroplasty. 
The purpose of the present study was to evaluate whether there is a correlation between 
procedure volume and the risk of revision following total knee arthroplasty. 
Methods: Thirty-seven thousand, three hundred and eighty-one total knee arthroplasties that 
were reported to the Norwegian Arthroplasty Register from 1994 to 2010 were used to 
examine the annual procedure volume per hospital. Hospital volume was divided into five 
categories according to the number of procedures performed annually: one to twenty-four 
(low volume), twenty-five to forty-nine (medium volume), fifty to ninety-nine (medium 
volume), 100 to 149 (high volume), and ‡150 (high volume). Cox regression (adjusted for 
age, sex, and diagnosis) was used to estimate the proportion of procedures without revision 
and the risk ratio (RR) of revision. Analyses were also performed for two commonly used 
prosthesis brands combined. 
Results: The rate of prosthetic survival at ten years was 92.5% (95% confidence interval, 





95.5% (95% confidence interval, 94.1 to 97.0) for hospitals with an annual volume of >150 
procedures. We found a significantly lower risk of revision for hospitals with an annual 
volume of 100 to 149 procedures (relative risk = 0.73 [95% confidence interval, 0.56 to 
0.96], p = 0.03) and ‡150 procedures (relative risk = 0.73 [95% confidence interval, 0.54 to 
1.00], p = 0.05) compared with hospitals with an annual volume of one to twenty-four 
procedures. Similar results were found when we analyzed two commonly used prosthesis 
brands. 
Conclusions: In the present study, there was a significantly higher rate of revision knee 







Higher revision risk for unicompartmental knee arthroplasty in low-volume hospitals 
Mona Badawy, Birgitte Espehaug, Kari Indrekvam, Leif I Havelin & Ove Furnes 
Acta Orthopaedica 2014; 85 : 342–347 
 
Background and purpose — Some studies have found high complication rates and others 
have found low complication rates after unicompartmental knee arthroplasty (UKA). We 
evaluated whether hospital procedure volume influences the risk of revision using data from 
the Norwegian Arthroplasty Register (NAR). 
Materials and methods — 5,791 UKAs have been registered in the Norwegian Arthroplasty 
Register. We analyzed the 4,460 cemented medial Oxford III implants that were used from 
1999 to 2012; this is the most commonly used UKA implant in Norway. Cox regression 
(adjusted for age, sex, and diagnosis) was used to estimate risk ratios (RRs) for revision. 4 
different volume groups were compared: 1–10, 11–20, 21–40, and > 40 UKA procedures 
annually per hospital. We also analyzed the reasons for revision. 
Results and interpretation — We found a lower risk of revision in hospitals performing 
more than 40 procedures a year than in those with less than 10 UKAs a year, with an 
unadjusted RR of 0.53 (95% CI: 0.35–0.81) and adjusted RR of 0.59 (95% CI: 0.39–0.90). 
Low-volume hospitals appeared to have a higher risk of revision due to dislocation, 







Oxford Unicompartmental Knee Arthroplasty in the Nordic countries: effect of 
hospital procedure volume on revision rates. 
12 986 cases from the Nordic Arthroplasty Register Association, 2000-2012. 
Mona Badawy, Anne M Fenstad, Kari Indrekvam, Leif I Havelin, Otto Robertsson, Anette 
W-Dahl, Antii Eskelinen, Keijo Mäkelä, Alma B Pedersen, Henrik Schrøder, Ove Furnes. 
Submitted 
Background and Purpose Survival of unicompartmental knee arthroplasty (UKA) is in part 
determined by procedure volume. The volume of UKA is much lower than total knee 
arthroplasty (TKA) in most hospitals worldwide, so the aim of this study was to quantify 
hospital volume effect on revision risk. The second objective was to assess different 
statistical methods used in calculating procedure volume and to implement the previously 
described methods of counting hospital procedure volume into one statistical model. 
Methods 12 986 cases were analysed from the NARA database over a 13 year time span 
since January 1st 2000 to December 31st 2012. The volume-revision rate relationship was 
assessed and quantified utilizing multivariate regression techniques and characterized 
graphically. 
Results Hospitals with low procedure volume and usage had an increased risk of revision 
compared to higher volume hospitals in the single statistical models, whereas the combined 
model showed only minor differences. Hospitals with consistent high volume over time, 
using a 3-year moving average, improved their results. The revision rate gradually improved 
from a moving average of 25 procedures per year; when performing a moving average of 75 
cases per year we found RR=0.8 (0.6-1.1). 
Interpretation Various statistical models have been utilized determining the effect of 
procedure volume on the risk of revision in UKA surgery. Depending on how the statistical 





survival of Oxford III UKA varied and therefore must be interpreted with caution. Hospitals 
with consistent high volume in the 3-year moving average analysis had improved results 
compared to the 3-year moving average less than 25 UKA per year. Continuous experience 





6. GENERAL DISCUSSION 
 
6.1 Methodological Considerations 
 
6.1.1 Study Design 
Registry studies are observational, contrary to randomized clinical studies which are 
investigational. The effectiveness of a device is measured by how well it performs in a 
general population of patients with wide selection criteria with multiple confounding factors 
such as cause of knee disease, the stability and axis of the knee preoperatively, level of 
comorbidity, as well as activity level, age and gender.  
Planning a registry study involves identifying the specific data set required for analysis, 
determining the outcome and endpoint and identifying inclusion and exclusion criteria. 
Registry studies can answer research questions like clinical practice in a historical 
perspective, measure effectiveness and safety of different devices, assess subgroup 
differences in treatment outcome due to high external validity (heterogeneous patient 
populations), short – and long term follow-up of devices and evaluation of current medical 
practice. They are complementary to clinical trials as they provide different information 
(128).  
Arthroplasty registers were developed to detect early implant or method failure. Common 
statistical analysis techniques in registry studies are Kaplan-Meier analysis and Cox 
regression (125). The Kaplan-Meier method was originally developed to investigate events 
occurring in all patients, i.e. death. Estimating the survival of arthroplasty, some patients will 
die before revision, but the method assumes that competing events do not exist, thus 





in confounding variables such as gender, distribution of age and various diagnoses when 
comparing survival estimates.  
There is continuing debate regarding the value of registry data. Its value lies in the ongoing 
monitoring and identifying different outcomes in a country or countries combined without 
excluding any hospitals, patients or implant brands (130).  
Methodological guidelines for statistical analyses and presentation of results has improved 
the reliability for randomized clinical trials through the CONSORT guidelines (131). For 
observational studies, the STROBE statement (132) has provided a checklist of items that 
should be included in reports of observational studies. Recently, RECORD guidelines of 
routinely collected data was created as an extension to the STROBE statement to address 
reporting items specific to observational studies using routinely collected health data (133). 
Additionally, the Nordic Arthroplasty Register Association (NARA) group has developed 
statistical recommendations for analysis of registry data (126, 127). Due to the need for large 
groups of patients and hospitals in our studies, a RCT would not have been possible for this 
purpose.  
NAR studies are mainly prospective observational studies where the primary joint 
replacement surgery is followed until the occurrence of revision surgery or death of the 
patient. Thus, the time interval from primary surgery till revision of the implant represents 
the “survival” of the implant, often defined in years. 
The advantage of a registry study for our purpose was the representation of all surgeons in 
all hospitals in Norway (NAR) and in Sweden, Denmark, Finland and Norway (NARA) 
including different experiences, techniques and skills, gaining a high external validity. The 
national registries evaluate implants and techniques in a real-world environment resulting in 
more generalizable findings. The disadvantage is the risk of uneven distribution of 
confounding factors in the study groups. Despite the fact that adjusting for different 
confounders in the analysis is utilized, there still will be possible unknown confounders not 





RCTs are considered the golden standard with the highest level of evidence. However, RCTs 
may not represent the average surgeon or hospital. Clinical trials establish causality while 
national registers are collecting data and monitoring differences within the country. Both 
clinical trials and registry studies are important tools towards the achievement of improved 
outcome in knee replacement surgery. Both provide valuable information. The main goal for 
arthroplasty surgery is improving function and satisfaction compared to pre-surgery, to 
diminish the pain and to avoid complications. Patient reported outcome measures are not 
included in the registry data and hence not in these studies. 
 
6.1.2 Outcome Measure 
An observational register study was the best option to answer the research question on 
current medial practice in TKA and UKA regarding hospital caseload on an annual basis and 
the changes over time. There could be ethical challenges associated with the conception of 
randomized controlled studies regarding the effect of caseload on outcome, randomizing 
patients into the lowest volume group with possible risk of receiving an inexperienced team.  
Due to the high degree of registration completeness, the results from registry studies are 
accurate. Improvement over time has been demonstrated for TKA, and is probably caused by 
better implants, surgical and cementing techniques with revision as endpoint. The time to 
first revision is an indication of a problem with the index operation requiring further surgical 
intervention (134). 
A limitation to evaluating TKA and UKA results by revision alone without patient reported 
outcome measures is the relatively large proportion of dis-satisfied patients. Revision as 
endpoint is an outcome measure that disguises the number of patients with unrevised 
implants that are unhappy with their knee due to pain or functional imparity (67).  
Patient reported outcome measures (PROM) would add valuable information concerning 
patient satisfaction. The NAR wishes to implement prospective PROM data in the register, 





Differences in mortality and major complications are additional outcome measures to be 
considered when choosing between UKA and TKA (135, 136). This has to weigh up the 
differences in rates of revision. 
Radiological investigations are another outcome measure that could add valuable 
information regarding indications both for primary and revision surgery and the evaluation 
of quality of surgery. Confounding by indication is a possibility, both regarding the degree 
of OA before primary surgery and regarding the actual reason for revision stated in the 
registry form. 
 
6.1.3 Completeness and Quality of Registry Data 
In Norway, all hospitals performing knee arthroplasties report to the NAR. However, the 
patients are not obliged to consent to registration to the NAR. To obtain complete 
registration in the future, presumed consent should substitute the current written consent.  
The completeness of registered knee surgery is calculated using the following formula: 
Registered in NAR only + Registered in both registers 
Registered in NPR only+Registered in NAR only+Registered in both registers 
 
Compared with the National Patient Register (NPR), the completeness for primary knee 
arthroplasty was 95.3% and for knee revisions 88.9% in 2008-2012. These analyses are 
conducted every second year and are presented in the annual report. The linkage between the 
two registers is done using the unique personal identification number of the patients. 
The completeness varies between hospitals from 78-100%. Low completeness of reporting 
could be due to lack of submitting the registry form or application of a wrong surgical code 
to the NPR. Reported revisions vary between hospitals from 48-100%.  
The registration completeness for all the Nordic countries is reported in the NARA report. 





registration completeness, DKR 97%, NAR 95.3% and SKAR (Swedish Knee Arthroplasty 
Register)  97.2%, FAR (Finnish Arthroplasty Register)  91.6% (119) . 
 
6.1.4 Validity 
Validity of registries consists of four aspects; coverage, registration completeness of 
procedures, registration completeness of variables and the accuracy of registered variables. 
Accuracy is the probability that variables are registered correctly. Validation studies are part 
of the registries’ publications (62, 137-140) 
Internal validity in observational studies may be threatened by confounding, selection bias or 
information bias. The association between exposure and outcome may be influenced by 
confounding factors that allows alternative explanations for an observed relationship 
between variables. To avoid mixing of effects in registry studies, either regression 
techniques or stratification can be used. Multiple regression analyses were used in all papers 
in this thesis to control for confounding. Additionally, the materials in paper II and III were 
also restricted by implant brand, and by diagnosis in paper III. It is important to control or to 
eliminate confounding variables to maintain the internal validity of the study.  
Selection bias occurs when the sample of the study is unrepresentative due to either under-
coverage (inadequately represented population) or nonresponse bias (unable/unwilling 
participants in the study leading to low response rate). In the NAR 95.3% of all primary knee 
replacements was reported and 97.6% to the NPR during the period from 2008-2012. 88.9% 
of all revision surgery was reported during the same time period to the NAR and 88.5% to 
the NPR. Reporting to the NAR is voluntary, whereas information to the NPR is mandatory. 
A study on registration completeness in the NAR was also published in 2006 (138). Our 
studies relied on the high registration completeness to obtain accurate and unbiased results.  
Information bias or misclassification could be systematic errors either in obtaining 
information or incorrect registration. Some hospitals have low registration completeness, and 





leading to excellent results in the register. Misclassification regarding implant brand is not 
likely in the NAR due to use of reference codes on the stickers on the register report from the 
hospitals regarding implants and cementing. However, misclassification could occur creating 
hospital volume categories and also regarding whether implants are classified as revised or 
not due to registration and clerical errors. Nevertheless, the high degree of registration 
completeness diminishes the risk for the variables mentioned. The 3 studies are based on 
data from the NAR and the NARA where selection bias and nonresponse bias is unlikely due 
to near completeness of reporting and complete follow-up of revisions and death. 
External validity is defined as the ability to generalize results and conclusions from the 
current study population to populations outside that particular community or country. 
Arthroplasty register studies are considered to have a broad range of patients and hospitals 
and therefore greater generalizability than i.e. RCT studies. Concomitantly, one could argue 
that the results are valid for the restricted population of Norway or the Nordic countries with 
similar population and health service.  
Precision occurs in the absence of random errors and is normally high in studies with large 
samples such as registry studies. However, the number of revisions is small in our studies, 
and to make reliable conclusions based on small numbers increases the need for 
collaboration with other similar registries. Paper III therefore was a consequence of and 
expansion of the small numbers of revisions in paper II.  
 
 
6.1.5 Statistical Methods 
The starting point in analysis of survival data in arthroplasty registers is the date of primary 
surgery and the endpoint is the date of revision of the primary implant. Censored 
observations include unrevised implants as well as implants in persons who died or 
emigrated. The most commonly used survival analyses in registries are the Kaplan-Meier 






The survival function is calculated as the cumulative probability that an implant will not be 
revised through various time intervals and is commonly presented as a table or a graph (141). 
For knee arthroplasty, the Kaplan-Meier analysis estimates the probability of the implant 
surviving (not being revised) a given length of time after primary surgery; i.e. a 2-, 5-, or 10-
year cumulative survival can be quoted. 
The log rank test, used in paper II, is a hypothesis test, comparing the survival distributions 
of independent groups. It was used to compare implant survival among volume groups with 
revision due to pain only, infection, loosening, dislocation, instability, malalignment, 
fracture, or to progression of osteoarthritis (OA) as endpoint. However, as the log-rank test is 
purely a significance test, it cannot provide an estimate of the size of the difference between 
groups and a related confidence interval (142). Secondly, the Kaplan–Meier method and the 
log-rank test can only study the effect of one factor at the time, and therefore they cannot be 
used for multivariate analysis. For these purposes, the Cox proportional hazards model a 
regression technique was used (143). 
Cox Regression Model 
This is a common method in analysing survival data and it enables estimation of the effect of 
covariates on the hazard rate(144). It is commonly used in arthroplasty register studies when 
several variables are investigated at the same time. To avoid selection or confounding bias 
that may affect the validity of the results, adjustments by the Cox proportional hazards 
regression model can be made. (126). A strong assumption is made that the effects of the 
different variables on survival are constant over time visualized by the separation between 
the curves remaining proportional across analysis time. Two ways of investigating 
proportionality is by use of the log minus log plot or Schoenfeld residuals (145). 
While Kaplan-Meier survival curves illustrates unadjusted results regarding implant survival, 






Investigating death as competing risk, Fine and Grey competing risk models can be used 
(129) and is an alternative to treating death as censored observation, thus avoiding 
underestimation of survival probabilities. 
Bilateral observations should also be included in the analyses. While this theoretically may 
affect the results, arthroplasty register studies assume that the revision risks for uni- or 
bilateral implants are identical (146). Ignoring bilaterality seems not to affect risk estimates.  
Pearson chi-square test was used to test whether proportions of specific revision causes 
differed among volume groups in paper II.  
Linear regression model was fitted for the 3 different methods in paper III by plotting Cox 
estimated risk ratios for each volume observation. Regression analysis was used to describe 
the linear dependence of the risk ratio from hospital volume. The black dots (scatter of 
observed data) around the fitted line indicate hospitals with a certain procedure volume 
(Fig.20). The 95% confidence interval (CI) is shown in greyscale. The CI gets wider with 
increasing distance from the mean. The vertical axis represents the relative risk of revision, 
and RR<1 demonstrates a decreased risk of revision in comparison to the average patient 
(RR=1). The regression line fitted in our sample is computed with the degree of uncertainty 
of our estimate by calculating the 95% confidence interval of the regression line (147). 
Multiple linear regression analysis allowed estimation of the linear effect after controlling 
for the confounding effect of other variables. 
 
6.1.6 Procedure Volume Calculations 
The numerical definitions assigned to hospital volume categories assessing effect on 
outcome, vary between studies. Katz defined TKA low volume hospitals as <25 procedures 
annually (81), whereas Hervey defined low-volume as <85 (80). Some used actual patient 
numbers while others used statistical measures like quartiles (148). Since there were such 
widespread differences in in hospital volume definitions for total knee arthroplasty surgery, 





define cut-point for volume categories based on clinical evaluation of the existing material 
and comparable previously used volume categorization in paper I and II (78, 81, 93, 148).  
To our knowledge there were few previous papers analyzing the volume effect on the 
relative risk of revision for TKA (93, 149). 
In paper I annual hospital volume was counted for each year separately, thus some hospitals 
changed volume group during the study period. We chose 5 volume categories from 1-24, 
25-49, 50-99, 100-149 and ≥150. Since no uniform categorization existed in the literature, 
the cut points were chosen based on evaluation of the current material in the NAR and other 
comparable studies available. Demographics were comparable in all the 5 volume groups 
(age, gender, diagnosis). All procedures were entered into the corresponding hospital TKA 
volume group 1-5 according to the number of primary TKAs at the hospital in the year of the 
procedure. There were 49 hospitals performing the TKA procedure during the study period. 
Hospitals with changing procedure volumes therefore could contribute to more than one 
volume group. 20 hospitals remained in the lowest volume group throughout the study 
period. 6 hospitals changed group one time, 22 hospitals changed 2 times to increasing 
volume groups, and 3 hospitals contributed to 4 volume groups. None contributed to all five 
groups.  
The method of counting each year separately for every hospital had not previously been used 
to our knowledge, but was later used in the TKA hospital volume study by Pamilo et al. in 
2015 (150). Fluctuating hospital procedure volume was also utilized by Glassou et al. in 
2016 in their study regarding hip arthroplasty (151). The advantage of this method of 
analysis is that if a hospital for 1 or more years belongs to the lowest-volume group, it 
actually reflects the rarity of the procedure that particular year. Even if a surgeon had a 
reasonable surgery volume during previous years, continuous training in a technically 
demanding procedure is essential to achieve reproducible results. One limitation of the study 
was the lack of information on surgeon procedure volume, and there was no information 
regarding the correct/incorrect indication for the subsequent primary procedure or revision. 
The gradual improvement of the survival following total knee arthroplasty is probably 





high volume probably include not only improved surgical technique but also a better 
understanding of the importance of patient selection and the indications for surgery. Better 
implants, implant-specific education, better surgical and cementing techniques are also 
important factors (103). 
In paper II, our method of counting procedures corresponded to Paper I, counting each year 
separately. Annual hospital procedure volume was calculated for all hospitals as the number 
of cemented Oxford III UKAs performed during a calendar year from January 1st until the 
December 31st. The effect of center volume was analyzed further by grouping the hospitals 
into four categories of approximately equal size according to the volume of primary 
procedures performed during the study period; 1-10, 11-20, 21-40 and >40. Patients were 
entered into the hospital volume groups according to the number of procedures at their 
hospitals the year of surgery. For every hospital, each year was examined individually. 51 
hospitals performed Oxford III UKA procedures during the study period, and 36 of those 
contributed to more than one volume group.  
Both Robertsson et al. and Baker et al. used average procedure volume in their papers (97, 
102) defining the mean procedure volume for the hospital during a given period of time. 
Robertson et al. analysed 10 474 UKA over a 10 year period, while Baker analysed 23 400 
UKA during an 8-year span. Our study had a lower number of patients (4 460), but over a 
14-year period. The more recent study by Liddle et al. included 37 131 UKA over 8 years 
(104). They calculated each surgeon’s UKA volume for each calendar year and then used the 
mean volume. Years with zero performance were excluded to prevent artificial reduction in 
caseload for surgeons who stopped performing UKA for any reason (104). Liddle et al. also 
used another method of determining the effect of caseload of UKA; as a percentage or 
proportion UKA compared to the total number of knee arthroplasties (61).  
Several new publications appeared during our publication of paper II, investigating the 
procedure volume effect on revision risk after Oxford UKA using alternative calculation 
methods. Therefore, our third publication assessed to compare different statistical methods 





Paper III was a NARA study including Oxford III UKA data from 4 countries’ registers 
(Sweden, Denmark, Finland and Norway), hospital procedure volume was calculated in 3 
methods previously described in the literature and finally added into one model. As implant 
brand and type could be a source of confounding in comparison of revision rate according to 
hospital, all other brands and types than Oxford III UKA were excluded. Diagnoses other 
than OA were excluded as inflammatory disease is a contraindication. Hospitals with less 
than 10 Oxford procedures during the complete study period were excluded from the 
material and considered an extremely low volume. The study period was 13 years; hence 10 
procedures during the entire period would mean less than 1 as a mean number of UKAs.  
The first calculation of hospital volume was similar to Paper I and II, counting each year for 
every hospital separately. Quartiles were used to make 4 hospital volume groups; <13, 13-
25, 26-45 and >45. Patients were entered into the hospital volume groups according to the 
number of procedures at their hospitals the year of surgery. This led to a distribution of UKA 
procedures that were relatively equal in each volume group. Due to the large number of 
hospitals changing volumes from year to year, this was our method of choice. To capture the 
variances happening in hospitals for different reasons, such as a decrease in volume of cases 
due to bad experience with the implant or dedicated surgeons moving to another hospital or 
retiring from work, analysing each year separately addresses this issue more properly in our 
opinion than an average volume would. 
The second method was the previously described average volume used by i.e. Baker et 
al.(102), in which we analyzed the procedure volume performed during the entire study 
period of 13 years and calculating the mean number of operations per year, using the total 
hospital volume as nominator and the actual numbers of years as denominator. When 
calculating average procedures volume, any year without reported procedures did not count. 
Consequently, if a hospital had zero procedures in 2 out of 10 years examined, the mean 
number of UKA operations was calculated over 8 years instead of 10 years. The measures of 
3 hospital volume categories were chosen based on equal sizing of the 3 groups (<12, 12-26 
and >26) according to the procedure volume performed during the entire study period and 





hospital volume above 50 a year, and that reflects the problem in choosing this method when 
the majority of hospitals are low volume. 
One could argue that mean volume over the whole time period is a more reliable method: if 
hospital A suddenly reduces its annual procedure volume to less than 10 but in the preceding 
5 years has had a high annual procedure volume of > 40, the team knows the procedure so 
well that one random year with a low volume would not have an impact on the results. 
However, since 36 of the 51 hospitals changed volume group during the study period, the 
advantage of the first method of analysis was that if a hospital for 1 or more years belonged 
to the lowest-volume group, it actually reflected the rarity of the procedure those particular 
years. If the hospitals had relatively constant annual hospital procedure volumes, an average 
number would be an appropriate method of choice. 
The third method was described by Liddle et al. (61), adding the volume of all knee 
replacements performed by the hospitals or surgeons. The purpose of this method was to 
determine the optimal usage defined as the percentage of knee arthroplasty practice 
comprised by UKA. This method would catch the proportion of highly selective units, 
offering UKA only to a small proportion of patients requiring arthroplasty of the knee, and 
consequently performing few UKAs each year. We decided to use their recommended 
threshold value of acceptable results with usage >/< than 20% in our study. Consequently, 
157 hospitals performed ≤20% UKA compared to 22 hospitals with >20%. Thus, only 
20.4% of the patients were operated at hospitals with a recommended Oxford III usage of 
>20%.  
In the study from Liddle et al., acceptable results were achieved with the use of 20% or 
more. Optimal results were achieved with usage between 40% and 60% and surgeons with 
the lowest usage (up to 5%) had the highest rates of revision. Liddles study also had 
generally low UKA procedure numbers where most surgeons performed very few (81.4% 
performed fewer than ten UKAs per year). In total, 8.3% of arthroplasties were UKAs. The 
mean number of cases performed annually per surgeon was 2.8 for UKA and 31.1 for TKA. 
Excluding the 1338 (50.5%) surgeons who performed no UKAs, these figures were 7.6 and 





11.0%. Even if NJR has a much larger statistical material, our material and results are 
corresponding to theirs. 
To avoid confusion using different groupings in the 3 different methods and the similarity 
between method 1 and 2, we constructed a combined model, implementing the previously 
described methods into one fitted Cox model; Oxford III UKA annual hospital volume, 
proportion/usage of Oxford III UKA, and TKA annual hospital volume in addition to 
including sex, age, calendar year of surgery and nation as adjustment variables.  
Using a 3-year moving average estimate as a proxy for surgeon experience, to avoid the 
random effect of sudden decreases in volume due to i.e. a surgeon moving to another 
hospital generated a set of smoothed estimates. 
When a high number of hospitals have low procedure volumes, the low procedure volume 
units will be reported as operating approximately at the national standard. Increasing and 
continuous volume could independently  be associated with quality (i.e., practice makes 
perfect), and current low volume could be a consequence of previously observed poor 
quality (152). 
 
6.1.7 Revision Causes 
Revision is defined as a partial or complete removal/exchange/addition of implant 
component(s). Revisions are linked to the primary surgery by the unique national 
identification number of the patient, laterality and specific joint. In the NAR, more than one 
reason for revision can be reported for one patient. When more than one reason is reported, 
there is a hierarchy with infection as the top reason for revision and pain only at the bottom. 
Addition of implant components is common in TKA when adding a patellar component, but 
in study II and III, UKA were studied, and there is no addition of components.  
In paper II, in the material restricted to revised implants, the Pearson chi-square test was 





log-rank test was used to compare implant survival among volume groups with revision due 
to infection, aseptic loosening or polyethylene wear, dislocation, instability, malalignment or 
fracture, progression of OA or pain alone (in hierarchical order from top to bottom) as 
endpoint. The logrank test is most likely to detect a difference between groups when the risk 
of an event is consistently greater for one group than another and was therefore considered 
appropriate for this purpose. The numbers of revisions in each group were too small to allow 
us to make any conclusions regarding the differences between the groups. In the >40 group 
there were only 26 revisions registered. Because the logrank test is purely a test of 
significance it cannot provide an estimate of the size of the difference between the groups or 
a confidence interval, thus to make assumptions about the data we should have included a 
risk ratio using Cox proportional hazards model (142). 
In paper III, there were 1344 revisions after cemented medial Oxford III UKA. Revision due 
to all reasons as well as specific causes for revision were analysed. The various reasons for 
revision were organized hierarchically with infection first and pain alone last. They were 
analysed using risk ratio with 95% confidence interval to test whether proportions of specific 
revision causes differed between the groups. Adjustments were made in the analysis for 
gender, age, time period and nation. The numbers of revisions were more evenly distributed 
in the different volume groups in this paper than in paper II in method 1 and 2. Using the 
Cox proportional hazard model enabled an estimate of the size of the differences between the 








6.2.1 Paper I 
 6.2.1.1 Patient and Procedure Characteristics 
 
In 1995, 88% of Norwegian hospitals performed less than 50 TKAs a year. In contrast, 84% 
of the hospitals performed more than 50 procedures a year in 2010. There has been a gradual 
increase in number of procedures every year regarding the total knee arthroplasty procedure. 
This is confirmed by data in the NAR report; 3954 TKA implanted in 2010, increasing to 
4930 in 2014. Hospitals with more than 100 TKA procedures a year was first registered in 
1999 and hospitals with >150 TKA a year in 2005. 
17.5% of the TKA were in the lowest volume group of <25, 28.1% in the 26-50 group, 
39.5% in the 51-100 group , 8% in the 100-149 group and 6.9% in the ≥150 group. Thus, the 
lowest number of implants was in the highest volume groups. 47 hospitals performed less 
than 25 TKA a year, 29 hospitals contributed to the 25-49 group, 26 hospitals performed 
between 50-99 TKA annually, 4 hospitals contributed to the 100-149 a year group, whereas 
only 2 hospitals performed ≥150 TKA annually.  
23 different TKA implant brands were registered in the NAR from 1994-2010. Prosthesis 
brands registered in less than 100 knees during the study period were excluded as well as 
hinged implants and PS/CCK designs. Due to small numbers of revision arthroplasties in 
each group and since all implant brands were not represented in all groups, we were not able 
to make adjustments for implant brands in the Cox model. Consequently, we decided to 
assess 2 commonly used implant designs combined in a subanalysis (AGC (Biomet, 
Warsaw, Indiana) and LCS (Depuy, Warsaw Indiana)). Implant variations could be a source 
of confounding in any comparison of revision rates according to hospital, and we considered 





Regarding sex, the <25 group had the lowest percentage of male patients (29%), whereas the 
100-149 group had the highest percentage (37%). Sex could be considered a demographic 
risk factor, but in a recent review article, 10 publications were considered and inconsistent 
findings were reported on whether males had a higher risk of revision surgery in general 
(153). Men do however have a twofold risk of revision due to infection in arthroplasty 
surgery compared to women found in several studies (154-156), but infection is (97) a minor 
cause of revision compared to the total number. In this study, we did not examine sex as an 
independent risk factor, but made adjustments for sex in the Cox model. 
Age as an independent risk factor, has been reported in 13 of 15 examined papers in the 
review article (153) previously mentioned. Revision rates decreased with older age. National 
registries have also reported on the age-influence on revision rates in arthroplasty surgery. 
Younger age has been associated with higher activity levels and higher levels of expectations 
as possible reasons for increased risk of revision. The median age values in this study were 
72 in the two lowest volume groups and 70 in the highest volume group. 
The majority of TKA patients had OA as reported diagnosis in our study. The lowest volume 
group <25 had the lowest percentage of OA diagnosis (81%), whereas the 100-149 group 
had 90% OA patients. A higher proportion of inflammatory diseases in the lowest volume 
group could lead to higher revision risk in this group. Estimated risk ratios were however 
adjusted for diagnosis in this study. Kreder et al. reported no association between OA and 
the risk of revision (149), whereas others found mixed results (153, 157). Diagnosis could be 
a source of information bias due to incorrect registration from surgeons. Secondary causes of 
OA may be underrepresented, but this has not been validated. 
Comorbidities could be a potential confounder increasing the risk of revision. Obesity, 
cardiac disease and diabetes has been associated with higher risk of revision(153). We did 
not assess ASA status in this study since it was first included for registration in 2005. 
Knee implant factors, such as fixation status, patellar resurfacing and posterior cruciate 
ligament sacrificing could potentially affect the risk of revision. In this study these factors 






 6.2.1.2 Survival Analyses 
 
The risk of revision was assessed in comparison with the results for the lowest volume 
procedure group <25. In conclusion, low volume hospitals had an increased risk of revision 
after primary TKA in that study. The two highest volume hospitals had statistically 
significantly lower risk of revision compared to the lowest volume group in the Cox 
regression analysis. Annual volume from 100-149 had RR=0.73 (0.56-0.96), p=0.03, and 
annual volume >150 had RR=0.73 (0.54-1.0), p=0.05. The two medium volume hospital 
groups had a slightly lower risk of revision than the <25 group, but not statistically 
significant.  
In the subanalysis of the AGC and LCS implants combined, we found similar and 
corresponding results. Comparing the hospitals with annual hospital volume 100-149 to 
hospital with annual volume <25, we found RR=0.56, p=0.007. For the other groups there 
were no statistically significant differences. 
Limitations to the study were other relevant factors contributing to continuous improvements 
in TKA; improvements in surgical technique and better implants and materials as well as 
evolving implant-specific education and increasing surgeon volumes. The increasing focus 
over the years on improving technique regarding placement of the components, improving 
ligament balancing and range of motion as well as cementing technique could also influence 
the results and cannot be controlled for and these measures have taken place parallel to the 
increase in hospital volume. A method to assess early revisions due to technical issues could 
be dealt with dividing into early and late revisions. Other factors to be considered 
confounders are BMI, comorbidity, smoking, educational level, preoperative pain and 
function levels which were lacking in this study.  
In view of the literature, our findings are in agreement with the findings of other earlier 





of England and Wales have supported the correlation between provider volume and revision 
risk after TKA (104). A recent study from the Finnish arthroplasty register found that lower 
volume hospitals were associated with longer length of stay and more readmissions than 
higher volume centers (150). The relationship between volume and outcome in knee 
replacement procedures has been studied by several groups. Some studies examined hospital 
volume, some examined surgeon volume. Most of the older studies examined outcome as 
frequency of mortality, morbidity, length of stay or financial outcomes (158, 159). Some 
studies examined the relationship between volume and risk of revision (102, 103). 
 
6.2.2  Paper II 
      6.2.2.1  Patient and Procedure Characteristics 
 
During the period of analysis from 1999-2012, approximately 10% of all knee replacements 
were unicompartmental. While TKA procedures have increased constantly during the years, 
the number of UKA has been relatively unchanged. However there has been an increase the 
last years of registration with  584 (10.5%) UKA in 2014 and 746 UKA in 2015. 
21.6% of UKAs were in the ≤10 annual volume group, 34.6% in the 11-20 group, 36.6% in 
the 21-40 group and 7.2% in the >40 group. Thus, the lowest number of implants belonged 
to the highest volume group. 49 of the 51 operating hospitals contributed to the ≤10 group, 
34 hospitals contributed to the 11-20 group, 22 hospitals contributed to the 21-40 group, 
whereas only 5 hospitals had a yearly volume of >40 UKAs. 
12 different UKA implant brands were registered in the NAR, and the Oxford III UKA 
implant constituted 72% of UKAs during 1994-2014. The Oxford Partial Knee was 
introduced in Norway in 2012, and is gradually replacing the Oxford III implant. The Oxford 
Partial Knee is a further development of the Oxford III implant, but will not be discussed in 
this context. In this study, all implant brands other than Oxford III were excluded to obtain 





Median age for UKA was substantially younger than for TKA; 65 years versus 71 years 
respectively. The lowest volume group of ≤10 UKA a year had the youngest patients with 
median age 62 while the other groups had median age of 65. Additionally, 37% of patients in 
the ≤10 group were ≤60 years of age compared to 28% in the highest volume group >40. 
This was supported by Liddle et al. who found younger patients in the low volume group 
(104). All registers report poorer results in young patients (53, 62, 160, 161). Liddle et al. 
also found age to be an important predictive factor (105). As previously discussed, age is an 
independent risk factor.  
Male sex was more common in UKA patients compared to the TKA population in paper I; 
between 43-47% men in the 4 UKA volume groups versus 29-37% men in the 5 TKA 
volume groups respectively. 47% male patients was registered in the lowest volume group of 
≤10 a year, whereas 43% were in the group with yearly procedure volume of >40 UKA.  
OA was registered in 94% of the cases in the highest volume group versus 91% in the ≤10 
UKA a year group. 
 
 6.2.2.2 Survival Analyses 
 
The risk of revision was assessed in comparison with the results for the lowest volume 
procedure group 1-10. In the unadjusted analysis, the 11-20 group had a lower risk of 
revision; RR=0.77 (0.62-0.96), p=0.02, the 21-40 group had RR=0.78 0.62-0.97), p=0.03 
and the >40 group had RR=0.53 (0.35-0.81), p=0.003. Risk of revision were similarly 
analysed with adjustments for sex, age and diagnosis. Patients in the hospital volume group 
of >40 had the lowest risk of revision; RR=0.59 (0.39-0.90), p=0.01 compared to the lowest 
volume group. We also found a linear trend between the groups; increasingly better results 
with increasing hospital volume. 
As in paper I, a limitation to this study was the lack of information on surgeon UKA 





surgeons in each hospital by the previously mentioned survey (appendix 3). 39 of the 42 
performing orthopaedic departments responded, and the enquiry suggested a high number of 
low-volume surgeons equally distributed among the volume groups. This can make the 
interpretation of hospital volume somehow uncertain, since high volume hospitals 
theoretically could have only low-volume surgeons and low-volume hospitals could have 
only one surgeon performing all the UKA procedures. 
Hospitals with the lowest procedure volume, having the highest rates of revision, implanted 
UKAs in younger patients than high volume hospitals. This could represent patients with 
partial thickness disease and poor indication for arthroplasty surgery. However, the register 
does not provide radiographic information. 
Our analysis was limited to the cemented medial Oxford III UKA implant, which may limit 
the generalizability of the findings, as the influence of hospital volume appeared to be 
implant dependent in the study from Robertsson et al. (97). They suggested that technically 
demanding implants were more susceptible to the influence of procedure volume. Whether 
or not the Oxford III UKA is more technically demanding than other UKA implants remains 
to be studied further.  
The common denominator in all UKA volume studies is the low caseload both regarding 
surgeon and hospital caseload over the years. The increasing focus from joint registries 
regarding the influence of caseload may improve UKA results in the coming years. 5 
hospitals had a yearly volume of >40 Oxford III UKAs in our study, and they had superior 
results compared to the lower volume centers. This could be an indication that the hospitals 
involved have dedicated UKA surgeons with proper knowledge of indications for primary 
and revision surgery as well as proper surgical technique. 
 The comparison against TKA is difficult since the disease pattern with isolated medial OA 
and the preoperative functional status of the patients’ knees is different from the typical TKA 
candidate. Nevertheless, UKA has inferior results compared the TKA even for the highest 





hospitals compared to 92.5% 10 year survival for the lowest TKA hospital volume group 
(<25) in paper I. 
In view of the literature, both Baker et al. (102) and Liddle et al. (104) suggested that 
surgeon caseload was an important measure regarding Oxford UKA. The correlation 
between hospital caseload and the risk of revision in UKA has been supported by Robertsson 
et al. (97) in the Swedish registry study. They found worse results with less than 23 UKA 
procedures a year. Baker et al. concluded with a minimum procedure number of 13 (102) 
and the New Zealand registry reported poorer results with less than 10 UKA a year REF. 
The study from the NJR of England and Wales concluded with optimal usage between 40-
60% UKA usage, and acceptable results with usage more than 20% UKA REF. In another 
paper, Liddle et al. found the revision rate after UKA to drop steeply until it reached 10 
cases a year, plateauing at 30 cases (104).  
 
 6.2.2.3 Revision Causes 
 
We analysed the distribution of revision causes for 514 revisions among the hospital volume 
groups. The main finding, was a higher proportion of revisions for pain alone in the high 
volume group >40, but this was not statistically significant (Pearson p-value =0.1). Revision 
causes like instability, fractures, malalignment and dislocation were more common in the 
lower volume groups than in the high volume group. These causes of revision could be 
considered technical errors during surgery. However, log-rank tests did not show any 
statistically significant differences between the groups. Additionally, the numbers of revision 
were small, and therefore, we recommended cautious interpretation of those findings. Liddle 
et al. found that reasons for revision differed among the volume groups, where low-volume 
surgeons were more likely to revise due to aseptic loosening, unexplained pain or 





Other outcome measures such as risk of postoperative complications or readmission post-
surgery and patient-reported outcome should also be taken into consideration in decision-
making on whether to choose UKA or TKA. In a propensity-score matched study, UKA had 
better short-term patient-reported outcome for the best outcomes and excellent results (136). 
Lygre et al. found similar results, however small, in a Norwegian registry study (117). 
Complications and readmissions were more common after TKA in the NJR study. The use of 
unicompartmental knee replacement was associated with substantially lower mortality than 
was TKA in another study from the NJR of England and Wales (135). Comparing matched 
patients in a study from the NJR of England and Wales, TKA patients had a higher risk of 
mortality, readmissions and complications than UKA patients. In the same study UKA had 
worse results regarding revision than TKA at 8 years (162). This had also been stated in the 
observational study by Hunt et al.; measuring the 45-day mortality after 467,779 knee 
replacements for osteoarthritis from the National Joint Registry for England and Wales. The 
use of unicompartmental knee replacement was associated with substantially lower mortality 










6.2.3 Paper III 
 6.2.3.1 Patient and Procedure Characteristics 
 
Our study included data from 4 different national registers with multiple surgeons and 
hospitals with varying experience and caseload, suggesting high external validity. It reflects 
the current practice in 4 different countries. 
NARA data showed that 126 different hospitals performed 12 986 cemented medial Oxford 
III UKA during 2000-2012. There was a substantial increase in numbers of hospitals 
performing Oxford III UKAs from 2002 to 2008, and then again the number of hospitals 
decreased. The increase in performing hospitals was not due to an increase in numbers of 
UKA, meaning lower volumes in more hospitals (Fig.21). 
 
Fig.21 Bar graph showing the change in number of hospitals performing Oxford III UKA 
(blue), the mean procedure volume per year (red), numbers of hospitals operating upon <12 
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There were also a large proportion of young patients; 18% were younger than 55 years, 
whereas only 13% were more than 75 years old. Other studies have shown that young 
patients experience an increased risk of revision after UKA compared to older patients (56, 
105, 161, 163).  W-Dahl et al. and Liddle et al. (105, 161) also found that older patients had 
the greatest benefits and the lowest revision rates. The increase in younger patients operated 
upon despite the knowledge of higher revision rate could be important explanation 
mechanisms for poor results. UKA has been associated with lower rates of morbidity and 
mortality compared to TKA (105, 135, 164, 165), and could therefore be a safer option for 
the elderly population, contrary to current practice 
We found that 43% of the patients were male. Gender was not found to influence the results 
in our study. 
We found that even though Denmark had the highest proportion of procedures in the annual 
volume groups in method 1, they only had 18% of high-users >20% in method 3. Finland 
had a majority of low-volume hospitals in method 1 and correspondingly only 10% high-
user hospitals. Norway similarly had most patients in the low-volume hospitals in method 1, 
whereas 34% were high-users in method 3. Sweden had an even distribution in all volume 
groups in method 1, while 20% were high-usage hospitals in method 3. Denmark had 
statistically significant higher risk ratio compared to Sweden as reference; RR=1.4 (95% CI 
1.2-1.6, p<0.001). Similarly, Norway had RR=1.2 (95% CI 1.0-1.5, p=0.02). Finland had 
RR=1.2 (95% CI 1.0-1.4, p=0.06). Why Sweden had the best implant survival of all the 4 
countries could be a result of longer period of training and experience, starting 
unicompartmental knee arthroplasty surgery and a knee arthroplasty register before the other 
Nordic countries, and thereby gaining more experience. In the Swedish Knee Arthroplasty 
Register , medial UKA was a popular procedure until 1995. Due to inferior results with high 
revision rates, a gradual drop in usage has been observed since then, and is now 3% of the 
total usage of knee replacements (63). Sweden differs from the other nations with only 50% 
of the implanted UKAs being Oxford and thus their learning curve could be improved by 






 6.2.3.2 Survival Analyses 
 
We studied the annual hospital procedure volumes in detail and found great variability from 
one year to the next, probably due to changing surgeon availability and surgeons’ method of 
choice for the treatment of knee osteoarthritis. A hospital with a high volume of 40 for 2-3 
years could suddenly have 5 procedures the next year, and in method 1, this particular 
hospital would be evaluated both in the high and the low volume group, respectively.  The 
reason for the change in yearly hospital volume is probably due to a change in available 
surgeons or a sudden change of practice or political decisions. Using <13 Oxford III UKA 
annual hospital volume as reference in method 1, all the higher volume groups had a lower 
risk of revision. 
Average volume over the whole time period resulted in an annual upper caseload threshold 
at >26 to get equal groups for comparison, which is a low volume compared to method 1. 
This corresponds to the Swedish study where 75% of the units performed less than 23 UKA 
per year (97). Baker used the total volumes over an 8-year time-span, and therefore had less 
than 50 as the lowest volume and more than 400 as the highest volume in his study from 
2014. A volume of 100 procedures therefore equated approximately 13 procedures a year 
(102). We found a 30% increased risk of revision in hospitals with an average annual 
hospital caseload of <26 UKA. 
The usage or percentage method (method 3) added an interesting aspect to the procedure-
outcome relationship. Only 20.4% of the patients were operated at hospitals with a 
recommended Oxford III usage of >20%. RR was 1.4 (95% CI 1.2-1.7, p<0.001) for the 
patients operated upon by low-usage hospitals ≤20% compared to the hospitals with higher 
usage percentage >20%. The method suggests more dedication to the indications and 
procedures when performing for instance 100 total knee arthroplasties and 30 
unicompartmental knee arthroplasties in an institution versus a hospital with a caseload of 
200 TKA and 20 UKA. If some hospitals have 30% of the available patient population 
suitable for UKA and other hospitals only find 10% of patients suitable for Oxford UKA, 





In addition to using Kaplan-Meier survival analysis and adjusted Cox regression models, we 
expanded the statistical analyses by adding fitting linear regression models. This enabled the 
study to visualize the distribution of procedure volume among the hospitals as well as 
achieving a more accurate threshold value regarding recommended UKA usage. 
We limited the analyses to the latest time period from 2000 excluding older implants and 
techniques. A limitation to the study could be unmeasured factors such as primary indication 
(166) as patients with full cartilage loss at the time of surgery are most likely to have relief 
of pain and improved function after knee arthroplasty, and thereby avoid the “pain alone” 
indication for revision surgery (67). Only hospital procedure volume was available for 
analysis in the NARA database, surgeon caseload and experience were not available. Ideally 
a high volume surgeon in a high volume center would gain the best results according to a 
systematic review regarding surgery volume (167). They stated, however, that the volume of 
a center had an equal if not greater effect on patient outcome than surgeon volume. We 
consider it a strength to the study limiting the analysis to one implant brand in the purpose to 
exclude possible confounder of implant type. Others have found surgeon volume to be 
volume-dependent in comparison to hospital volume (102). 
Analyzing the combined Cox model previously described, with the risk of revision as a 
function of the annual hospital volume, patients operated at hospitals with a hospital volume 
of between 25 (median value) and 53, had a lower risk than the median patient.  Inferior 
implant survival was found in hospitals with annual volumes of less than 25 UKAs and more 
than 53. The results were however not statistically significant, and the differences could only 
be interpreted as tendencies of improved or poorer results, as opposed to the single analyses. 
The 3-year moving average model was constructed to smooth out year-by-year fluctuations 
in annual procedure volume. This was done in order to prevent bias regarding surgeons 
leaving the hospital leading to a sudden decrease in volume and also a drop in experience. 
The results indicated that hospitals with consistent high volume over a 3 year period had 
improved results compared to lower volume units. Adding the prior years of experience in 
the moving average, fell favorably for high volume hospitals. Hospitals with continuous high 





from 25 procedures per year.  The term ‘consistent’ high hospital volume used in the results 
and discussion section refers to hospitals performing high volumes of Oxford III UKA for 
more than 1 random year of high volume.  We examined all hospitals with procedure 
volumes >50 per year and found that 8 hospitals had 1 random year of high volume with 
various revision numbers. 7 hospitals had consistent high volume over a 5-6 years period, 
where the numbers of revisions decreased during the observed time period.   
 
 
 6.2.3.3 Revision Causes 
 
The interpretation of the differences found among the different volume groups regarding the 
causes of revision is difficult. There were statistically significant differences between the 
groups for some causes of revision. Pain alone in addition to loosening and wear were more 
common reasons for revision in the lowest volume group. These could be explanations to the 
differences in revision rates, suggesting a lower revision-threshold in low-volume users. 
However, the >45 group in method 1 had similar results as the <13 group regarding revisions 
due to aseptic loosening. This could explain why some high volume hospitals have inferior 
results in the combined Cox model. The group “other” was heterogeneous, consisting of both 
fractures, progression of osteoarthritis and malalignment, so to draw any certain conclusions 
on this matter could be biased. Similar results were found in our previous NAR study, 
however without statistical significance, probably due to smaller numbers of revision (168).  
In this study there were 1344 revisions after Oxford III UKA and they were evenly 









 We found a gradual increase in the number of TKA registered in the NAR during the 
study period. 17% of the included TKAs were operated in hospitals with an annual 
hospital volume <25 TKA, 28% were operated in hospitals with 25-49 procedures 
annually, 40% in hospitals with 50-99 TKA per year, 8% in hospitals with 100-149 
per year and 7% in hospitals with more than 150 TKA procedures per year. 
 In this study, we found a significantly higher risk of revision following knee 
arthroplasties performed in low-volume hospitals as compared with high-volume 
hospitals with better prosthesis survival at hospitals performing >100 TKA per year. 
Paper II 
 We found consistent low numbers of UKA registered in the NAR during the study 
period; approximately 10% of all knee replacements. 22% of UKAs were operated in 
hospitals with <10 procedures per year, 34% in hospitals with 11-20 per year, 37% in 
hospitals with 21-40 per year and 7% in hospitals with more than 40 UKA per year. 
 This registry-based study confirmed that the risk of revision was significantly higher 
for hospitals performing less than 10 Oxford III UKA procedures a year than for 
those performing more than 40 Oxford III UKA procedures a year in Norway 
between 1999 and 2012. 
 Low-volume hospitals appeared to have a higher risk of revision due to dislocation, 






 We identified 4131 (31.6%) Oxford III implants in Denmark in 32 different 
hospitals: 2180 (16.8%) in Sweden distributed among 18 hospitals, 3826 (29.6%) in 
Finland in 41 hospitals and 2849 (21.9%) in Norway in 35 hospitals. 
 A minimum hospital volume of at least 25 Oxford III UKA a year seemed to improve 
the implant survival in this study. A consistent high volume over years showed a 
tendency of improved results, lowering the risk of revision. 
 This study identified hospital volume as an important predictor affecting implant 
survival of the cemented medial Oxford III UKA utilizing different statistical 
methods of measurement. We recommend a combined use of methods to evaluate 
procedure volume as they separately add valuable information.  
 Revision for pain alone was lower in all higher volume hospital groups as compared 
to low volume hospitals. 
 
National registries should discourage hospitals from performing UKA at low numbers as the 
risk of revision increases for all causes at low-volume hospitals. In our studies we found 
improved results when performing >100 TKA per hospital per year, >25 UKA per hospital 
per year and thus a usage of >20% UKA appears to be a reasonable measure achieving 
acceptable results. Nevertheless, risk of revision is higher for UKA than for TKA in most 






8. IMPLICATIONS AND FUTURE RESEARCH 
Knee replacement surgery is increasing worldwide as an increasingly younger and more 
obese population has painful joints due to osteoarthritis. The current population is probably a 
more demanding group of patients to satisfy in terms of function, pain and expectations than 
previous generations with more advanced chronic disease. Thus the largest increase in 
patients receiving knee arthroplasty is the elderly patients. Satisfaction after total knee 
replacement has been reported in large study populations of no more than 80% (28). The 
survival of the prosthesis has been the main goal for surgeons for years and has reached a 
satisfactory level in national registers. The goal to achieve a forgotten joint a year after 
surgery remains unachievable for a large number of patients (170). However, total knee 
replacement has proved to improve outcome compared to nonsurgical treatment (30). 
Aseptic loosening, malalignment, instability, fracture and pain are reasons for early revisions 
that could represent technical failures. Regarding alignment, there is increasing interest in 
restoring the patient’s normal kinematics as opposed to mechanically aligned TKA, 
suggesting a higher proportion of satisfaction in the kinematically aligned group (29, 171) . 
The complexity of total knee arthroplasty regarding successful outcome, includes positioning 
and sizing of the implants in addition to ligament balancing and limb alignment.  
All these factors are dependent on surgeon experience, but total knee arthroplasty is a 
common procedure bypassing hip replacement in volume in some countries, thus the volume 
effect will decline as time goes by and most surgeons and centers are categorized as high 
volume. Nevertheless, a new study with expanded numbers of years with additional high 
volume TKA hospitals could be recommended. 
UKA has worse implant survival than TKA. However mortality and complication rates are 
higher for TKA than for UKA (135, 162, 164). The inferior implant survival should be 
addressed continuously by registers worldwide with emphasis on the large population of 
low-volume surgeons and units. In a recent study from the UK, 81.4% of the surgeons 





unacceptable high number of low-volume performance. Less than 10% of knee arthroplasties 
are UKAs in national registers (53, 62, 160, 172), so the caseload is basically low. Registers 
should continue to monitor the UKA volume and to encourage low volume hospitals to refer 
their UKA cases to higher volume units for improved results (61, 168). The NAR has 
encouraged surgeons through the annual reports to limit this procedure to a few dedicated 
surgeons in as few hospitals as possible, to achieve revision risk that is comparable with that 
of the TKA procedure. This seems to have had effect, as the latest report from 2015 showed 
an increase in UKA to 746 compared to earlier years with between 400-500 UKA annually. 
Fewer hospitals now perform UKA procedures (33) and there seems to be a larger amount of 
higher volume hospitals, as 9 of the 33 hospitals performed more than 30 UKA in 2015. 
Future research regarding the effect of volume on results should focus on the possible 
differences in patient selection, differences in causes of revisions, differences in revision 
threshold and differences in surgical skills. Revision causes such as early aseptic loosening, 
fractures and development of lateral OA should be prevented to achieve results comparable 
to TKA (56). Patient selection is important in UKA as a typical misapprehension is to 
choose UKA for younger patients with early-stage disease. Revisions without a certain cause 
such as pain alone specified as the main factor is also more common in low-volume units 
(paper III). Concomitantly, UKA revisions might be more straightforward than TKA 
revisions, which could lower the revision threshold for some surgeons. This could be 
examined by a review of previous pre-UKA revision radiographs. This would be a highly 
interesting but time-consuming study. Knee revision surgery is also widespread low-volume 
surgery. A study to assess the volume-effect on revision surgery with concomitant 
assessment of method of choice and implant constrained among hospitals could reveal the 
risk of re-revision. For the Nordic countries numbers of revisions are low, so a NARA study 
could facilitate higher number of cases.  
In the NAR and NARA, only hospital volume data is obtainable for analysis. There are pros 
and cons to this matter. For the surgeons, they can operate without the stress and insecurity 
of how the data of surgeon results will be handled by the government and by the media. The 





advantage is the opportunity to use the surgeon data in research for more accurate estimates 
of results in the hospitals. Learning curves for new implants and methods introduced can 
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